Submitted by Anonymous (not verified) on 14 January 2026 - 13:45
Human medicines European public assessment report (EPAR): Stoboclo, denosumab, Date of authorisation: 14/02/2025, Revision: 4, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Stoboclo, denosumab, Date of authorisation: 14/02/2025, Revision: 4, Status: Authorised